financingNoema Pharma AG closes Series B financingNoema Pharma AG receives €104m in oversubscribed Series B financing round to advance its central nervous system pipeline. more ➔
IPOOculis lists at Nasdaq through SPAC mergerThe eye disease specialist Oculis Holding AG has been listed on Nasdaq following the merger of Oculis SA with European Biotech Acquisition Corp. more ➔
financingMoney for AI-powered drug discoveryAntiverse Ltd.’s AI identified eight antibodies with therapeutic potential for humans and raised €2.8m in funding for continued in-house development. more ➔
partnershipConfo Therapeutics and Lilly partner to advance CFTX-1554Drug developer Confo Therapeutics and Eli Lilly & Company have inked a worldwide licensing agreement to co develop Confo’s neurophatic pain candidate CFTX-1554. more ➔
fundraisingGerman HTGF IV fund closes at €493mThe fourth fund of High-Tech Gründerfonds has reached a final fund volume of €493.8m more ➔
financing5 Alarm Bio Ltd raises £500K in seed roundBritish anti-aging therapeutics developer 5 Alarm Bio Ltd has raised £500K in a seed financing for testing its lead compound FAB001 for healing chronic wounds. more ➔
immunologyHigh blood pressure reprograms immune systemInterferon-gamma overexpression leads to hypertension-induced damage to the blood-brain barrier by reprogrammed macrophages. more ➔
financingAbivax SA raises €130m to advance obefazimod to Phase IIIFrench Abivax SA has raised €130m capital led by TCGX to accelerate Phase III testing of its ulcerative colitis candidate obefazimod extend its cashflow. more ➔
financingPaleo raised € 12 m in Series A financing roundMyoglobin producer Paleo NV has closed a € 12 m Series A round led by DSM Venturing and Planet A Ventures. more ➔
partnershipMinaris and LIfT BioSciences collaborate in cell therapy developmentCDMO Minaris Regenerative Medicine GmbH is to manufacture the leukocyte infusion therapy N-LIfT for LIFT BioSciences. more ➔
